Search results
After COVID vaccine rollout, negativity on Twitter spiked
Center for Infectious Disease Research and Policy· 3 days agoAfter the introduction of COVID-19 vaccines at the end of 2020, there was an average 10,201 more ...
New mRNA cancer vaccine triggers fierce immune response to fight malignant brain tumor
Medical Xpress· 2 days agoReported May 1 in the journal Cell, the discovery represents a potential new way to recruit the...
Hospitals ‘just not ready’ for an avian flu outbreak
Politico via Yahoo News· 9 minutes ago“We don’t have an adequate supply of the people to care for the people.” Trust in health systems also remains battered from the Covid wars over lockdowns, masks and vaccines
Pfizer profits drop on lower Covid-19 product sales
Digital Journal· 2 days agoPfizer reported a drop in profits on lower sales of Covid-19 related profits Wednesday as it steers investments to other pharmaceutical areas and...
Brain cancer in children is notoriously hard to treat – a new mRNA cancer vaccine triggers an attack...
The Conversation via Yahoo News· 2 days agoCancer vaccines have gained much interest among scientists but face a number of hurdles. A new mRNA ...
AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very...
Benzinga· 4 days agoEuropean pharma giant AstraZeneca Plc’s AZN Covid vaccine, developed with the University of Oxford,...
Vaccine Against Urinary Tract Infections in Development
Medscape· 2 days agoA randomized study published in 2022 showed the vaccine's efficacy in preventing urinary tract...
Moderna Shares Jump After Better-Than-Expected Sales
The Wall Street Journal· 18 hours agoModerna shares shot up about 7% Thursday after reporting better-than-expected quarterly sales and signaling confidence in a sales pickup later this year....
Cholera is making a comeback — and the world doesn’t have enough vaccines
Vox· 23 hours agoAmid a global resurgence of cholera, the world is fighting with one hand tied behind its back. The...
Man receives world’s first melanoma vaccine — trial underway
New York Post· 7 days agoThe Phase 3 trial hopes to recruit 1,100 people. The vaccine, called mRNA-4157 (V940) works...